| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.089 | 0.007 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.007 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.4 | 0.009 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.079 | 0.009 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.68 | 0.01 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.36 | 0.01 |